Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Loxo Oncology
Loxo Oncology
(LOXO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Jaypirca
Pirtobrutinib
2023-01-27
2036
Mantle-cell lymphoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pirtobrutinib
healthy volunteers/patients
,
burkitt lymphoma
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
,
preleukemia
,
syndrome
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
multiple myeloma
,
renal insufficiency
,
liver failure
,
hepatic insufficiency
,
large b-cell lymphoma diffuse
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
interdigitating dendritic cell sarcoma
,
follicular lymphoma
,
neoplasms
,
hairy cell leukemia
,
hematologic neoplasms
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
thrombocytopenic purpura idiopathic
,
central nervous system neoplasms
,
mantle-cell lymphoma
,
b-cell lymphoma
,
lymphoma
,
lymphoid leukemia
,
leukemia
,
hematologic diseases
,
recurrence
,
b-cell leukemia
,
reactive arthritis
,
b-cell chronic lymphocytic leukemia
,
non-hodgkin lymphoma
,
atrial fibrillation
,
sudden death cardiac
,
heart arrest
,
supraventricular tachycardia
CRELOSIDENIB
healthy volunteers/patients
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloproliferative disorders
,
myelomonocytic leukemia chronic
,
prostatic neoplasms
,
breast neoplasms
,
neoplasms
,
thyroid neoplasms
,
glioblastoma
,
glioma
,
central nervous system neoplasms
,
melanoma
,
colonic neoplasms
,
cholangiocarcinoma
,
chondrosarcoma
Olomorasib
non-small-cell lung carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use